AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oramed Pharmaceuticals Inc. Director's Dealing 2021

Dec 17, 2021

6965_dirs_2021-12-17_f080c107-b314-40a1-bc4d-26c218aa887e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2021-12-16

Reporting Person: RAKIN KEVIN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-16	Common Stock	G	5000	—	Disposed	52004	Direct

Footnotes

F1: This transaction represents a charitable donation effective December 16, 2021. This is not a market transaction, thus no price has been reported. No value was received for the donated shares.